Skip to main content

Table 1 Baseline demographic and clinical characteristics of participants by group

From: Evaluation of the effects of Artemisia Annua L. and Moringa Oleifera Lam. on CD4 count and viral load among PLWH on ART at Mbarara Regional Referral Hospital: a double-blind randomized controlled clinical trial

Characteristic

 

Control

Mean (SD) or n (%); (n = 74)

Artemisia

Mean (SD) or n (%); (n = 88)

Artemisia + Mor. Mean (SD) or n (%) (n = 86)

P value

Mean Age (years)

 

39.2 (8.7)

40.9 (9.8)

 

0.32

 

39.2 (8.7)

 

39.2 (9.9)

0.73

Gender

Male

49 (29.7)

56 (33.9)

60 (36.4)

0.69

Female

25 (30.1)

32 (38.5)

26 (31.3)

Education level

Primary +

68 (30)

78(34.4)

81(35.7)

0.42

None

6 (28.6)

10 (47.6)

5 (23.8)

Income

Regular

10 (43.5)

8 (34.8)

5 (21.7)

0.23

Not regular

63 (28.1)

80 (35.7)

81 (36.1)

BMI (kg/m2)

< 19

8 (28.6)

8 (28.6)

12 (42.9)

0.90

19–24

51 (29.8)

61(35.7)

59 (34.5)

25–29

11 (27.5)

17 (42)

12 (30)

30+

3 (37.5)

2 (25)

3 (37.5)

Have a spouse

Yes

12 (36.4)

12 (36.4)

9 (27.3)

0.80

No

43 (28.3)

57 (37.5)

52 (34.2)

N/A

13 (31.0)

13 (31.0)

16 (38.1)

Mean no of children/ household

 

2.2 (1.2)

 

2.6 (2.7)

0.93

 

2.2 (1.2)

2.2 (2.1)

 

0.36

Mean duration on ART (months)

 

62.2 (41.1)

166.1 (1021.3

 

0.26

 

62.2 (41.1)

 

53.4 (36.7)

0.19

Mean WBC (103 cells/µl)

 

3.4 (2.7)

3.5 (2.3)

 

0.30

 

3.4 (2.7)

 

4.2 (4.3)

0.23

Mean RBC (106 cells/µl)

 

4.5 (0.8)

4.4 (0.6)

 

0.76

 

4.5 (0.8)

 

4.5 (0.6)

0.33

Mean Hb level (g/dl)

 

14.3 (4.6)

13.7 (2.8)

 

0.76

 

14.3 (4.6)

 

14.0 (2.9)

0.29

Mean CD4 count (cells/µl)

 

221.8 (88.9)

214.7 (86.6)

 

0.55

 

221.8 (88.9)

 

227.5 (75.7)

0.89

Mean LVL

 

6.0 (2.1)

6.2 (2.4)

 

0.68

 

6.0 (2.1)

 

6.0 (2.2)

0.63

ART regimen

AZT/3TC/EFV

20 (27.0)

24 (27.3)

23 (26.7)

0.31

AZT/3TC/NVP

13 (17.6)

15 (17.0)

16 (18.6)

3TC/EFV/TDF

41 (55.4)

49 (55.6)

47 (54.7)

  1. ART: antiretroviral therapy; AZT: Zidovudine; BMI: body mass index; 3TC: Lamivudine; EFV: Efavirenz; LVL: log viral load; NVP: Nevirapine; RBC: red blood cells; TDF: Tenofovir, WBC: white blood cells
  2. Data from the intervention groups and the control groups were compared using chi-square analysis for categorical variables and the Wilcoxon rank-sum (Mann-Whitney) test for continuous variables. P-values less than 0.05 were considered statistically significant